Earnings Calendar - Aug 14, 2026
Showing earnings announcements on Aug 14, 2026
Name | Price | % Change | Company | Market Cap | EPS / Forecast | Revenue / Forecast | Time | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
 | $1.24 | After: -1.61% | Tvardi Therapeutics | $17.07M | xxxxxxxxxxxxx | |||||
 | $0.50 | After: +0.02% | Moleculin Biotech | $10.73M | xxxxxxxxxxxxx | |||||
 | $0.55 | After: +0.86% | Traws Pharma | $9.62M | xxxxxxxxxxxxx | |||||
 | $0.58 | After: +1.41% | Outlook Therapeutics | $152.33M | xxxxxxxxxxxxx | |||||
 | $0.54 | After: -2.35% | Citius Pharmaceuticals | $15.22M | xxxxxxxxxxxxx | |||||
 | $1.78 | After: -5.06% | Cerenome | $14.12M | xxxxxxxxxxxxx | |||||
 | $0.80 | After: 0% | Rani Therapeutics Holdings | $111.56M | xxxxxxxxxxxxx | |||||
 | $1.09 | After: -1.39% | Foresight Autonomous Holdings | $5.96M | xxxxxxxxxxxxx | |||||
 | $1.78 | After: +0.84% | Sidus Space, Inc. Class A | $185.24M | xxxxxxxxxxxxx | |||||
 | $4.02 | After: +0.75% | Clene | $58.28M | xxxxxxxxxxxxx | |||||
 | $0.85 | After: 0% | Rein Therapeutics | $68.15M | xxxxxxxxxxxxx | |||||
 | $0.28 | After: 0% | VistaGen Therapeutics | $13.22M | xxxxxxxxxxxxx | |||||
 | $0.60 | After: 0% | Jasper Therapeutics | $20.81M | xxxxxxxxxxxxx | |||||
 | $3.68 | After: +3.26% | Upland Software | $9.46M | xxxxxxxxxxxxx | |||||
 | $30.68 | After: 0% | Quince Therapeutics | $31.70M | xxxxxxxxxxxxx | |||||
 | $1.98 | After: +1.52% | TuHURA Biosciences | $131.91M | xxxxxxxxxxxxx | |||||
 | $1.60 | After: +1.87% | Skye Bioscience | $7.04M | ― | xxxxxxxxxxxxx | ||||
 | $20.93 | After: +0.33% | Perpetua Resources | $2.69B | xxxxxxxxxxxxx | |||||
 | $5.96 | After: +3.15% | Lifeward | $19.57M | xxxxxxxxxxxxx | |||||
 | $1.17 | After: +5.13% | Annovis Bio | $55.48M | xxxxxxxxxxxxx | |||||
 | $1.76 | After: +1.7% | Aptevo Therapeutics | $3.37M | xxxxxxxxxxxxx | |||||
 | $2.70 | After: +2.96% | PAVmed | $30.50M | xxxxxxxxxxxxx | |||||
 | $3.76 | After: 0% | Galectin Therapeutics | $394.32M | xxxxxxxxxxxxx | |||||
 | $2.10 | After: +0.95% | Femasys | $17.50M | xxxxxxxxxxxxx | |||||
 | $0.58 | After: -0.21% | Banzai International | $2.44M | xxxxxxxxxxxxx | |||||
 | $13.45 | After: +0.74% | Replimune Group | $1.22B | xxxxxxxxxxxxx | |||||
 | $4.38 | After: +1.14% | LeonaBio | $33.07M | xxxxxxxxxxxxx | |||||
 | $6.37 | After: 0% | New Era Energy & Digital | $720.34M | xxxxxxxxxxxxx | |||||
 | $5.42 | After: +2.21% | Super League Enterprise | $13.95M | xxxxxxxxxxxxx | |||||
 | $1.13 | After: +0.15% | Eightco Holdings | $507.14M | ― | xxxxxxxxxxxxx | ||||
 | $69.79 | After: 0% | Sabine Royalty | $1.02B | ― | xxxxxxxxxxxxx | ||||
 | $0.61 | After: +1.26% | Streamex | $78.68M | xxxxxxxxxxxxx | |||||
 | $1.31 | After: +0.13% | reAlpha Tech Corp. | $8.11M | xxxxxxxxxxxxx | |||||
 | $0.15 | After: +2.8% | SurgePays | $7.97M | xxxxxxxxxxxxx | |||||
 | $0.55 | After: +3.85% | Neumora Therapeutics, Inc. | $127.32M | xxxxxxxxxxxxx | |||||
 | $2.62 | After: -0.38% | Solana Company | $172.91M | xxxxxxxxxxxxx | |||||
 | $4.72 | After: 0% | Quoin Pharmaceuticals | $9.80M | xxxxxxxxxxxxx | |||||
 | $1.26 | After: 0% | Acurx Pharmaceuticals | $7.26M | xxxxxxxxxxxxx | |||||
 | $2.69 | After: +0.38% | Cycurion | $8.56M | xxxxxxxxxxxxx | |||||
 | $1.04 | After: 0% | Allarity Therapeutics | $15.36M | xxxxxxxxxxxxx | |||||
 | $6.20 | After: -1.94% | GT Biopharma | $12.41M | xxxxxxxxxxxxx | |||||
 | $6.09 | After: +0.33% | Brand Engagement Network | $44.55M | xxxxxxxxxxxxx | |||||
 | $1.69 | After: +0.03% | RLX Technology | $2.08B | xxxxxxxxxxxxx | |||||
 | $1.51 | After: -1.99% | Beneficient | $21.79M | xxxxxxxxxxxxx | |||||
 | $0.92 | After: -2% | Innovative Eyewear, Inc. | $8.05M | ― | xxxxxxxxxxxxx | ||||
 | $1.00 | After: +3% | Lantern Pharma | $13.87M | xxxxxxxxxxxxx | |||||
 | $0.96 | After: +1.88% | PowerCompute | $2.39M | xxxxxxxxxxxxx | |||||
 | $3.62 | After: +9.94% | Creative Media | $5.66M | xxxxxxxxxxxxx | |||||
 | $2.94 | PMET Resources Inc | C$586.22M | xxxxxxxxxxxxx | ||||||
 | $3.38 | After: +2.07% | Data Storage | $7.67M | xxxxxxxxxxxxx | |||||
 | $0.41 | After: -2.18% | Milestone Scientific | $37.16M | xxxxxxxxxxxxx | |||||
 | $49.21 | After: +0.45% | Bright Minds Biosciences | $490.64M | xxxxxxxxxxxxx | |||||
 | $0.18 | After: -2.2% | Scienture Holdings | $10.95M | xxxxxxxxxxxxx | |||||
 | $2.10 | After: +6.19% | Interactive Strength Inc | $3.73M | xxxxxxxxxxxxx | |||||
 | $1.19 | After: 0% | Edible Garden AG , Inc. | $2.38M | xxxxxxxxxxxxx | |||||
 | $0.17 | After: -2.85% | Algorhythm Holdings | $3.32M | xxxxxxxxxxxxx | |||||
 | $1.69 | After: 0% | HCW Biologics | $3.91M | ― | xxxxxxxxxxxxx | ||||
 | $0.78 | After: +2% | Greenland Technologies Holding | $22.30M | xxxxxxxxxxxxx | |||||
 | $0.15 | After: +1.21% | Vivos Therapeutics | $5.06M | xxxxxxxxxxxxx | |||||
 | $1.25 | After: +2.41% | 60 Degrees Pharmaceuticals, Inc. | $4.40M | ― | xxxxxxxxxxxxx | ||||
 | $0.28 | After: -0.04% | Silexion Therapeutics | $3.51M | xxxxxxxxxxxxx | |||||
 | $5.53 | After: 0% | LanzaTech Global | $77.10M | xxxxxxxxxxxxx | |||||
 | $8.34 | After: -0.9% | Sigma Lithium | $1.07B | xxxxxxxxxxxxx | |||||
 | $2.19 | After: +1.6% | Canton Strategic Holdings | $189.64M | xxxxxxxxxxxxx | |||||
 | $0.27 | Medicenna Therapeutics Corp | C$21.53M | xxxxxxxxxxxxx | ||||||
 | $4.40 | After: 0% | Americas Gold and Silver | $1.52B | xxxxxxxxxxxxx | |||||
 | $7.04 | After: 0% | LGL Group | $86.40M | xxxxxxxxxxxxx | |||||
 | $1.36 | After: +3.68% | TOMI Environmental Solutions | $11.32M | xxxxxxxxxxxxx | |||||
 | $6.00 | After: +0.83% | Flexible Solutions International | $73.70M | xxxxxxxxxxxxx | |||||
 | $1.74 | After: -2.3% | Quantum eMotion | $382.00M | xxxxxxxxxxxxx | |||||
 | $15.78 | After: 0% | Maui Land & Pineapple Company | $319.73M | xxxxxxxxxxxxx | |||||
 | $4.84 | After: -0.21% | Motorsport Games | $20.83M | xxxxxxxxxxxxx | |||||
 | $17.95 | Aviva | $27.56B | xxxxxxxxxxxxx | ||||||
 | $1.75 | After: -1.71% | PMV Pharmaceuticals | $107.98M | xxxxxxxxxxxxx | |||||
 | $1.06 | After: -1.89% | Newton Golf Company | $5.92M | xxxxxxxxxxxxx | |||||
 | $0.48 | After: +0.71% | Largo Resources | $54.31M | xxxxxxxxxxxxx | |||||
 | $8.49 | After: 0% | XMAX | $561.17M | xxxxxxxxxxxxx | |||||
 | $3.84 | After: 0% | CAMP4 Therapeutics Corporation | $245.37M | xxxxxxxxxxxxx | |||||
 | $0.98 | After: +3.06% | Citius Oncology | $97.63M | xxxxxxxxxxxxx | |||||
 | $15.89 | After: +0.42% | Boost Run | $1.40B | xxxxxxxxxxxxx | |||||
 | $0.13 | Arizona Metals | $18.38M | xxxxxxxxxxxxx | ||||||
 | $2.96 | Cosan | $2.84B | xxxxxxxxxxxxx | ||||||
 | $4.88 | Jaguar Mining | $431.40M | xxxxxxxxxxxxx | ||||||
 | $8.52 | AbraSilver Resource | $1.35B | xxxxxxxxxxxxx | ||||||
 | $15.76 | After: +1.97% | Adlai Nortye Ltd. Sponsored ADR | $1.01B | xxxxxxxxxxxxx | |||||
 | $201.42 | After: -0.7% | Primeenergy | $315.79M | ― | xxxxxxxxxxxxx | ||||
 | $3.97 | After: +0.25% | Digi Power X | $186.54M | xxxxxxxxxxxxx | |||||
 | $0.12 | Touchstone Exploration | $55.75M | xxxxxxxxxxxxx | ||||||
 | $0.88 | After: 0% | Barfresh Food Group | $13.86M | xxxxxxxxxxxxx | |||||
 | $9.87 | After: +3.85% | Hudson Global | $35.97M | xxxxxxxxxxxxx | |||||
 | $4.64 | After: -0.86% | Optimi Health | C$27.18M | xxxxxxxxxxxxx | |||||
 | $5.80 | Marimaca Copper | C$787.69M | xxxxxxxxxxxxx | ||||||
 | $1.09 | Steppe Gold | $291.14M | xxxxxxxxxxxxx | ||||||
 | $0.31 | Jaguar Financial | C$385.15K | xxxxxxxxxxxxx | ||||||
 | $15.51 | After: -0.45% | StablecoinX Inc Class A | $416.51M | xxxxxxxxxxxxx | |||||
 | $9.30 | After: 0% | Mako Mining Corp | C$835.36M | xxxxxxxxxxxxx | |||||
 | $14.97 | Sands China | $12.16B | xxxxxxxxxxxxx | ||||||
 | $0.42 | Kuya Silver | $62.87M | xxxxxxxxxxxxx | ||||||
 | $0.31 | Western Uranium | C$20.43M | xxxxxxxxxxxxx | ||||||
 | $0.56 | K2 Gold | C$141.18M | xxxxxxxxxxxxx |
Rows:
Earnings News
FAQ
When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
How do earnings affect stock prices?
A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
Is it better to buy a stock before or after earnings?
Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.